Analyses of 123 Peripheral Human Immune Cell Subsets: Defining Differences with Age and between Healthy Donors and Cancer Patients Not Detected in Analysis of Standard Immune Cell Types

doi:10.5772/62322

PMC full text:

J Circ Biomark. 2016 Jan-Dec; 5: 5.

Published online 2016 Mar 10. doi: 10.5772/62322

Copyright/LicenseRequest permission to reuse: Copyright © 2016 Author(s). Licensee InTech.
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Table 4.

Standard parental immune cell types in age-matched advanced cancer patients and healthy donors

An external file that holds a picture, illustration, etc.
Object name is 10.5772_62322-fig8.jpg

A total of 9 standard parental immune cell types were analyzed. Values are displayed as median % of PBMCs. P-value was calculated with the Mann Whitney test with Holm adjustment made for multiple comparisons using the number of standard immune cell types with frequency above 0.01% of PBMCs (n=9). Differences were defined as subsets with an adjusted p<0.05, medians at least 50% different, and frequency above 0.01% of PBMCs.

——–

cDC, conventional dendritic cells; MDSC, myeloid derived suppressor cells; NK, natural killer; PBMCs, peripheral blood mononuclear cells; pDC, plasmacytoid DC; Tregs, regulatory T cells.